Please find attached financial results approved by board of director in the meeting held today 10-05-2025 for the quarter and year ended March 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shentracon Chemicals reported audited FY25 results showing zero revenue from operations for the entire year, with only Rs 17.66 lakh in other income (vs Rs 0.02 lakh in FY24). The company posted a small pre-tax profit of Rs 0.60 lakh (vs a Rs 10.70 lakh loss in FY24), but an extraordinary charge of Rs 30.34 lakh towards premium paid on preference share redemption turned the bottom line into a net loss of Rs 29.90 lakh (vs Rs 10.70 lakh loss). EPS came in at Rs (0.67). The board did not recommend any dividend for FY25, citing growth plans and an uncertain environment. Statutory auditors Chanani & Associates issued an unmodified opinion, and a new internal auditor (Mr. D. Das) was appointed for FY24-25.
Negative net worth of about Rs 10 lakh, zero operating revenue, and negative operating cash flow of Rs 154.65 lakh signal stress on this micro-cap. Shareholders see no dividend and continued erosion of book value, with the stock likely to remain illiquid and news-driven rather than fundamentals-driven.